Key result
The COVID-19 pandemic was associated with a 73% reduction in de-novo pacemaker implantations (P<.001), including a 78% reduction in patients with complete or high-grade atrioventricular block.
Why the study?
Mandatory social isolation during the COVID-19 pandemic decreased activities in cardiology units, but its impact on pacemaker implantation volumes and etiologies required assessment.
Did the COVID-19 pandemic reduce the volume of pacemaker implantations?
Cross-Sectional
No
Did the COVID-19 pandemic reduce the volume of pacemaker implantations?
Effect estimate: 73% reduction
p-value: p=<.001
The COVID-19 pandemic and associated social isolation led to a 73% reduction in de-novo pacemaker implantations, highlighting a significant disruption in essential electrophysiology services.
Objectives: The purpose of this article was to determine the change in the volume of pacemaker implantations with the COVID-2019 pandemic and to assess the change in the number of pacemaker implants according to etiology during the pandemic. Background: The establishment of a mandatory social isolation have generated a decrease in activities in cardiology units. Methods: Descriptive, cross-sectional study that used a database of a Peruvian Hospital. Time was divided into three categories: Before COVID period and COVID period including Previous to Social isolation (SI) and Social Isolation. The number of pacemaker implantations were compared per the same amount of time. Results: < .001) was observed during the COVID-19 pandemic period, and a reduction of 78% of patients with the diagnosis of complete or high-grade atrioventricular block and a reduction in the de-novo pacemaker implant was observed, regardless of the etiology. Conclusions: Our results indicate a very significant reduction (73%) in de-novo pacemaker implantation during the months of the COVID-19 pandemic. The reduction in the number of de-novo pacemaker occurred independent of the etiology.
No takes yet. Share an insight, caveat, or question.
Gonzales‐Luna et al. (2020) conducted a cross-sectional in Pacemaker implantation. COVID-19 pandemic and social isolation vs. Before COVID period was evaluated on Volume of de-novo pacemaker implantations (73% reduction, p=<.001). The COVID-19 pandemic was associated with a 73% reduction in de-novo pacemaker implantations (P<.001), including a 78% reduction in patients with complete or high-grade atrioventricular block.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: